FY27 Revenue Target: ₹170-180 Cr
Hospital revenue expected at ₹50-60 Cr and clinic revenue at ₹100-110 Cr. Growth driven by bed capacity additions, marketing push targeting 2 lakh new patients annually.
VAIDYASANEAYURVEDLABORAT / guidance tracker
Keep management guidance in view.
Vaidyasaneayurvedlaborat · forward-looking guidance across the available source record.
Research layer active
Guidance tracker
What management said would happen.
revenue
FY28 Medium-term Revenue: ₹250-300 Cr
Hospital contribution targeted at ₹100-125 Cr from 250-300 beds; blended RPB expected at ₹70,000+ per bed.
EBITDA Margin Target: 20%+ by FY28
Margins expected to improve from ~15% in FY27 toward 20%+ by FY28 through higher patient enrollments and cost control; COGS already at 18% and well-managed.
Franchise Clinic Additions: 30-40 in Next ~18 Months
Asset-light franchise expansion prioritized in new geographies while strengthening existing 180-190 franchise clinics with increased patient footfall.